Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, *Half-Life∅, selectivity↑, *toxicity↓, Wnt/(β-catenin)↓, P53↑, P21↑, PI3K↓, Akt↓, mTOR↓, TumCCA↑, TumCI↓, TumCMig↓, STAT3↓, PKM2↓, EMT↓, cl‑PARP↑, Casp3↑, Bax:Bcl2↑, VEGF↓, Hif1a↓, Dose∅, GLUT1↓, GlucoseCon↓,
TumCP↓, cycD1/CCND1↓, Apoptosis↑, PI3K↓, Akt↓, ROS↑, Casp3↑, Cyt‑c↑, Bcl-2↓, TumCCA↑, Dose∅, ALP↓, LDH↓, PCNA↓, P53↑, Bax:Bcl2↑,
| - |
in-vivo, |
Colon, |
NA |
|
|
|
- |
Human, |
Nor, |
NA |
|
|
|
TumCG↓, HDAC↓, *BioAv↑, Dose∅, Half-Life∅,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis ⓘ
GlucoseCon↓, 1, LDH↓, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 2, Apoptosis↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 1, Casp3↑, 2, Cyt‑c↑, 1,
DNA Damage & Repair ⓘ
P53↑, 2, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, HDAC↓, 1, mTOR↓, 1, PI3K↓, 2, STAT3↓, 1, TumCG↓, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Drug Metabolism & Resistance ⓘ
Dose∅, 3, Half-Life∅, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
ALP↓, 1, LDH↓, 1,
Total Targets: 34
Pathway results for Effect on Normal Cells:
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, Half-Life∅, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 4
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:1114 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page